Merck Has Dutch Court’s Green Light To Close Oss R&D Ops

So it ends — it would seem. . .

Many media outlets now have versions of this story — here is one of them:

. . . .A Dutch court said Friday U.S.-based Merck & Co. Inc. (MRK) isn’t obliged to accept a bid for its Dutch Organon operations from a potential buyer, although the court said it needs to consult with Organon’s supervisory board, the works council and the unions on why it rejected an offer. . . .

Last month, Merck said it failed to find a buyer for the Dutch Organon operations after it announced in July last year that it would close its research & development sites in the Netherlands as part of a major global revamp. But strong resistance by the works council and Organon’s employees prompted Merck last September to look into alternative solutions. Shuttering the operations would result in cutting 2,000 of the 4,500 jobs at Organon’s research and development sites. . . .

This probably spells the effective end for Oss R&D — one of the first facilities to produce the original birth control pills — for Organon in the 1960s. We’ll keep you posted.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s